What to Include in a Company Profile for Biotech and Life Sciences Companies

A biotech or life sciences company profile should explain, in plain language, what problem you are solving, what stage your science has reached, who is on the team, and what you are looking for from the reader. It should be accurate to the point of being conservative: investors, partners, and regulators all read these documents closely, and an overstated claim does more damage than a modest one.

Why life sciences profiles are harder than most

Most companies can describe what they sell in a sentence. A biotech often cannot, because the product is years from market and the audience is mixed. The same document might be read by a generalist angel investor, a specialist venture partner, a pharma business development lead, a grant officer, and a prospective hire. Each wants something different, and none wants to wade through jargon to find it.

There is also a compliance dimension. Claims about efficacy, safety, or regulatory status are not marketing copy. Depending on your stage and jurisdiction, careless wording in a public document can create real problems. A good profile is written with that constraint in mind from the first draft.

What belongs in the profile

A one-paragraph plain-language summary

Start with the unmet need, your approach, and where you are. Aim for something a smart non-specialist could repeat to a colleague. If a sentence requires a glossary, rewrite it, and move the technical detail further down.

The science and the platform

Describe your technology, mechanism, or platform at the level a specialist would expect, but keep it grounded. Explain what is differentiated and why it matters. If your approach is built on published work, say so and reference it. If something is preliminary, call it preliminary.

Pipeline and stage

A simple table or list works best: each program, its indication, and its current stage, for example discovery, preclinical, or a specific clinical phase. Be exact. Partners will check, and a program labeled one stage in your profile and another in your data room erodes trust fast. If you have no clinical programs, do not imply otherwise.

Team, advisors, and institutional ties

In this sector, credibility is largely about people. Include founders’ relevant training and prior roles, key hires, scientific advisors, and academic or clinical partners. Keep bios short and factual. Name licensed technology and its source institution if that is public.

Intellectual property

State what you hold or have licensed in general terms, such as patent applications filed or licensed from a university, without disclosing anything confidential. Avoid vague phrases like “strong IP position” unless you can back them up in conversation.

Funding, milestones, and partnerships

Include non-dilutive grants, completed rounds you are comfortable disclosing, and past or current collaborations. Then list the next milestones in plain terms: what you plan to demonstrate, and roughly when. Milestones tell a reader what their involvement would help accomplish.

What you are asking for

Many profiles forget this. Say whether you are seeking investment, a licensing partner, a research collaborator, a contract manufacturer, or clinical sites. One clear sentence is enough.

What to leave out or handle carefully

Do not include unpublished data you are not ready to share publicly, and do not make efficacy or safety statements beyond what your data supports. Avoid superlatives such as “revolutionary” or “first-in-class” unless you can substantiate them. Do not list regulatory designations you have not received. If you are unsure whether a statement is appropriate, check with your counsel or regulatory lead before the document goes out.

Where the profile gets used

Common uses include investor outreach before a deck meeting, partnership discussions with larger companies, grant and accelerator applications, university technology-transfer conversations, recruiting, and conference follow-ups. Because it is a shorter, easier-to-forward document than a deck, it often travels further than you expect. For the distinction between the two, see our post on company profile vs. pitch deck vs. business profile. If your company grew out of academic research, our guide to university spinoffs and research commercialization covers related ground.

How Compaino can help

Compaino drafts a structured company profile from your existing website, or from a short questionnaire if you do not have one. For a life sciences company, the draft is a starting point: you should review every scientific and regulatory statement, correct anything that is imprecise, and add pipeline detail that is not on your site. It is built to leave gaps rather than invent facts, but a human with domain knowledge must sign off. You can generate a profile from your website, or use the questionnaire if your site is thin or not yet live, and see a preview before you pay.

Frequently asked questions

How technical should a biotech company profile be?

Lead with plain language and put technical depth in later sections, so both generalists and specialists get what they need.

Should a pre-clinical company include data?

Only data you are comfortable having public, summarized carefully. Anything more detailed belongs in a data room under NDA.

How often should it be updated?

After any financing, new program, major data readout, or regulatory milestone, and before any major outreach push. See how often to update a company profile.

Key Takeaways

• Open with a plain-language summary of the problem, approach, and stage.
• Be exact about pipeline stage and conservative about claims.
• Team and institutional credibility carry unusual weight in this sector.
• State clearly what you are looking for from the reader.
• Have a domain expert review any generated draft before it goes out.

Ready to start? Generate your company profile and review the preview before paying.